One of the challenges I am facing is that there is a gap between our molecular testing and clinical care for patients with Wolfram syndrome. I would like to establish a way to choose the best treatment options for each patient based on molecular testing. I have some idea, but it has not been fully implemented. Many patients donated cells and blood samples for molecular testing. So I need to bridge the gap as soon as possible.
Thank you for reading this. I appreciate your continued support and encouragement. Thank you, Thank you, Thank you.
With many thanks,
Fumi Urano